Neural Therapeutics Inc. (NURL) Price & Analysis

1 Followers

NURL Stock Chart & Stats

C$0.02

Market closed

C$0.02

Day’s Range― - ―

52-Week RangeC$0.01 - C$0.04

Previous CloseN/A

VolumeN/A

Average Volume (3M)331.48K

Market Cap

C$1.69M

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.03

Next Earnings

Nov 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding168,700,500

10 Day Avg. Volume453,922

30 Day Avg. Volume331,483

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Neural Therapeutics Inc. News

Neural Therapeutics Revises CWE Financing, Resets Shareholder Meeting and Grants RSUs

The latest announcement is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. has amended its...

4M ago

Neural Therapeutics Moves to Take Full Control of German CBD Retailer Hanf.com

An update from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics has applied to the...

5M ago

Neural Therapeutics’ Hanf.com Stake Delivers 58% Revenue Surge and Positive Operating Income

The latest update is out from Neural Therapeutics Inc. ( ($TSE:NURL) ). Neural Therapeutics Inc. reported that its...

5M ago

Neural’s Hanf.com Begins German Sales of Ritual Herbs Tobacco-Free Smoking Blends

Neural Therapeutics Inc. ( ($TSE:NURL) ) has provided an announcement. Neural Therapeutics’ portfolio company CWE European Holdings, operating...

6M ago

Neural Therapeutics Expands Hanf.com Retail Network in Germany

Neural Therapeutics Inc. ( ($TSE:NURL) ) just unveiled an announcement. Neural Therapeutics Inc. has announced the expansion of...

9M ago

Neural Therapeutics’ Portfolio Company Hanf.com Reports Strong Financial Growth

Neural Therapeutics Inc. ( ($TSE:NURL) ) has provided an announcement. Neural Therapeutics Inc. has reported strong financial results...

10M ago

Neural Therapeutics’ Partner Hanf.com Expands with New Store in Bavaria

Neural Therapeutics Inc. ( ($TSE:NURL) ) just unveiled an update. Neural Therapeutics Inc. has announced the opening of...

10M ago

Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com

An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the...

12M ago

Neural Therapeutics Gains Approval for Strategic Acquisition of German CBD Retailer

Neural Therapeutics Inc. ( ($TSE:NURL) ) just unveiled an announcement. Neural Therapeutics Inc. announced that CWE European Holdings...

1y ago

Neural Therapeutics Strengthens Ethnobotanical Strategy with Key Agreements

Neural Therapeutics Inc. ( ($TSE:NURL) ) has provided an announcement. Neural Therapeutics Inc. has announced two significant developments...

1y ago

NURL FAQ

What was Neural Therapeutics Inc.’s price range in the past 12 months?

Neural Therapeutics Inc. lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.

What is Neural Therapeutics Inc.’s market cap?

Neural Therapeutics Inc.’s market cap is C$1.69M.

When is Neural Therapeutics Inc.’s upcoming earnings report date?

Neural Therapeutics Inc.’s upcoming earnings report date is Nov 20, 2026 which is in 119 days.

How were Neural Therapeutics Inc.’s earnings last quarter?

Currently, no data Available

Is Neural Therapeutics Inc. overvalued?

According to Wall Street analysts Neural Therapeutics Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Neural Therapeutics Inc. pay dividends?

Neural Therapeutics Inc. does not currently pay dividends.

What is Neural Therapeutics Inc.’s EPS estimate?

Neural Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Neural Therapeutics Inc. have?

Neural Therapeutics Inc. has 168,700,500 shares outstanding.

What happened to Neural Therapeutics Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Neural Therapeutics Inc.?

Currently, no hedge funds are holding shares in TSE:NURL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Neural Therapeutics Inc.

Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.